v3.26.1
Unaudited Condensed Statements of Changes in Shareholders’ Deficit - USD ($)
Class A
Ordinary Shares
Class B
Ordinary Shares
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2025 $ 575 $ 24,425 $ (38,876) $ (13,876)
Balance (in Shares) at Dec. 31, 2025 5,750,000 [1]      
Net Income (Loss) (55,000) (55,000)
Balance at Mar. 31, 2026 $ 575 24,425 (93,876) (68,876)
Balance (in Shares) at Mar. 31, 2026 5,750,000 [1]      
Balance at Dec. 31, 2025 $ 575 24,425 (38,876) (13,876)
Balance (in Shares) at Dec. 31, 2025 5,750,000 [1]      
Net Income (Loss)         1,078,066
Balance at Jun. 30, 2026 $ 47 $ 575 (5,507,209) (5,506,587)
Balance (in Shares) at Jun. 30, 2026 470,000 5,750,000 [1]      
Balance at Mar. 31, 2026 $ 575 24,425 (93,876) (68,876)
Balance (in Shares) at Mar. 31, 2026 5,750,000 [1]      
Proceeds from private placement $ 47 4,699,953 4,700,000
Proceeds from private placement (in Shares) 470,000 [1]      
Public warrants, fair value 2,611,113 2,611,113
Public rights, fair value 1,331,579 1,331,579
Offering costs allocated to private placement (199,985) (199,985)
Accretion of carrying value to redemption value (8,467,085) (6,546,399) (15,013,484)
Net Income (Loss) 1,133,066 1,133,066
Balance at Jun. 30, 2026 $ 47 $ 575 $ (5,507,209) $ (5,506,587)
Balance (in Shares) at Jun. 30, 2026 470,000 5,750,000 [1]      
[1] Includes an aggregate of up to 750,000 Class B ordinary shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters (see Note 5). The underwriter fully exercised the over-allotment option on April 8, 2026. As such, no Class B ordinary shares were forfeited. On March 31, 2026, the Sponsor surrendered, for no consideration, 3,833,333 founder shares. Amounts have been retroactively restated to reflect the surrendered shares.